Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Xtant Medical Holdings, Inc.XTNT · Entity 7196 | Director | August 15, 2022 | August 17, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Xtant Medical Holdings, Inc.
Report date August 15, 2022 · Filed August 17, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.000001 par valueSEC Table I · non-derivative | Direct | 448,546 |
Reported balance
After 2022-08-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-08-15 · Grant · Acquired 215,415 · Balance 448,546 F1: These shares are subject to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, and vest and become issuable on August 15, 2023, conditioned upon the reporting person remaining a director of Xtant through the vesting date. F2: Includes 215,415 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, conditioned upon the reporting person remaining a director of Xtant through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares are subject to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, and vest and become issuable on August 15, 2023, conditioned upon the reporting person remaining a director of Xtant through the vesting date.
F2: Includes 215,415 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, conditioned upon the reporting person remaining a director of Xtant through the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2022 Filed Aug 17, 2022 20:50 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantCommon Stock, $0.000001 par value | 215,415 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-22-000099 · primary_doc.xml · nonDerivative · entry 1 Peters Jeffrey J · CIK 0001329814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 448,546 F1 · shares: These shares are subject to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, and vest and become issuable on August 15, 2023, conditioned upon the reporting person remaining a director of Xtant through the vesting date. F2 · balance_after: Includes 215,415 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, conditioned upon the reporting person remaining a director of Xtant through the vesting date. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 21:11 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantCommon Stock, $0.000001 par value | 85,337 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-21-000106 · primary_doc.xml · nonDerivative · entry 1 Peters Jeffrey J · CIK 0001329814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,131 F1 · shares: These shares are subject to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, and vest and become issuable on August 15, 2022, conditioned upon the reporting person remaining a director of Xtant through the vesting date. F2 · balance_after: Includes 143,436 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, conditioned upon the reporting person remaining a director of Xtant through the vesting date. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:28 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantCommon Stock, $0.000001 par value | 116,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-20-000005 · primary_doc.xml · nonDerivative · entry 1 Peters Jeffrey J · CIK 0001329814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,794 F1 · shares: These shares are subject to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, and will vest and become issuable with respect 58,098 shares on February 15, 2021 and with respect to 58,099 shares on February 15, 2022, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. F2 · balance_after: Includes (i) 116,197 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, conditioned upon the reporting person remaining a director of Xtant through the vesting date; (ii) 5,555 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, conditioned upon the reporting person remaining a director of Xtant through the vesting date, and (iii) 13,021 shares issued as part of a restricted stock award granted under the Amended and Restated Xtant Equity Incentive Plan, which shares are subject to forfeiture until vested. Read SEC document |
| September 24, 2019 Filed Sep 25, 2019 20:29 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantCommon Stock, $0.000001 par value | 5,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-19-000121 · primary_doc.xml · nonDerivative · entry 1 Peters Jeffrey J · CIK 0001329814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,597 F1 · shares: These shares are subject to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan and will vest and become issuable on February 15, 2020, conditioned upon the reporting person remaining a director of Xtant through the vesting date. F2 · balance_after: Includes 5,555 shares to be issued upon vesting pursuant to restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, conditioned upon the reporting person remaining a director of Xtant through the vesting date, and 13,021 shares issued as part of a restricted stock award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, which shares are subject to forfeiture until vested. Read SEC document |
| August 15, 2018 Filed Aug 16, 2018 21:09 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantCommon Stock, $0.000001 par value | 26,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-18-000124 · primary_doc.xml · nonDerivative · entry 1 Peters Jeffrey J · CIK 0001329814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,042 F1 · shares: These shares were issued pursuant to a restricted stock award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, such shares will vest with respect to 13,021 shares on each of February 15, 2019 and February 15, 2020 and are subject to forfeiture until vested. F1 · balance_after: These shares were issued pursuant to a restricted stock award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, such shares will vest with respect to 13,021 shares on each of February 15, 2019 and February 15, 2020 and are subject to forfeiture until vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.